22h
GlobalData on MSNAlphamab doses first subject in trial of JSKN003 for ovarian cancerAlphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...
SoundExchange, an unabashed supporter of artist rights and fairness for all creators across the music industry, is ...
Enterprise 2.0 Technologies Market The online communities segment is expected to experience fastest growth in the coming years WILMINGT ...
Rail Maintenance Management System Market Rise in IoT use and digitization witnessed in railway transport to drive the growth of rail maint ...
Deals, offers, competitions and more. Be the first to know the latest products you can get your hands on right now. Our team of experts hand select everything, providing reviews, advice and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results